| Completed | Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Metastatic Cancer, Solid Tumor | Phase 1 | 2020-11-19 |
| Completed | Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advance Metastatic Cancer, Solid Tumor | Phase 1 | 2020-10-12 |
| Withdrawn | Sym004 Versus TAS-102 in Patients With mCRC Metastatic Colorectal Cancer, Colorectal Cancer Metastatic, Carcinoma | Phase 3 | 2019-02-01 |
| Terminated | Sym004 Versus Futuximab or Modotuximab in Patients With mCRC Metastatic Colorectal Cancer, Colorectal Cancer Metastatic, Carcinoma | Phase 2 | 2018-11-29 |
| Completed | Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas Metastatic Cancer, Solid Tumor, Lymphoma | Phase 1 | 2018-05-24 |
| Completed | Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas Metastatic Cancer, Solid Tumor, Lymphoma | Phase 1 | 2018-05-08 |
| Completed | Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Pa Metastatic Cancer, Solid Tumor, Lymphoma | Phase 1 | 2017-11-20 |
| Withdrawn | Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients Metastatic Colorectal Cancer | Phase 2 | 2016-12-01 |
| Withdrawn | Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lu Squamous Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2016-11-01 |
| Terminated | Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies Oncology | Phase 1 / Phase 2 | 2016-11-01 |
| Terminated | Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients Metastatic Colorectal Cancer | Phase 1 / Phase 2 | 2016-03-15 |
| Completed | Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies Oncology, MET Gene Amplification, NSCLC | Phase 1 / Phase 2 | 2016-03-01 |
| Completed | Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2014-03-06 |
| Completed | Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy Carcinoma, Squamous Cell of Head and Neck | Phase 2 | 2011-07-01 |
| Completed | Sym004 in Patients With Advanced Solid Tumors Metastatic Colorectal Cancer | Phase 1 / Phase 2 | 2010-03-01 |
| Completed | Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP Immune Thrombocytopenic Purpura | Phase 2 | 2008-07-01 |